Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Azilect

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Introduction: Parkinson‟s disease (PD) is characterized by a chronic progressive loss of nigrostriatal dopaminergic neurons that… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2015
Highly Cited
2015
IMPORTANCE Depression, cognitive impairment, and other nonmotor symptoms (NMSs) are common early in Parkinson disease (PD) and… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2013
Review
2013
Rasagiline (Azilect(®)) is a selective and irreversible monoamine oxidase B inhibitor, which is well tolerated, safe, improves… Expand
Is this relevant?
2012
2012
This is a case report of a 69-year-old female with Parkinson's disease who developed an asymptomatic eruption on her legs… Expand
Is this relevant?
2012
2012
  • Rasagiline Azilect
  • 2012
  • Corpus ID: 48574610
KEY POINTS Rasagiline, like selegiline, is an irreversible monoamine oxidase type-B (MAO-B) inhibitor It inhibits the breakdown… Expand
  • table 1
Is this relevant?
2010
2010
Increasing evidence suggests that oxidative stress (OS)-induced pancreatic β-cell impairments is involved in diabetes and… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Novel therapeutic approaches for the treatment of neurodegenerative disorders comprise drug candidates designed specifically to… Expand
Is this relevant?
2008
2008
We recently reported that propargylamine derivatives such as rasagiline (Azilect) and its S-isomer TVP1022 are neuroprotective… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The anti-Parkinson monoamine oxidase (MAO)-B inhibitor rasagiline (Azilect) was shown to possess neuroprotective activities… Expand
Is this relevant?
Review
2006
Review
2006
The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action… Expand
Is this relevant?